Search results for "Blood Vessel"

showing 10 items of 323 documents

Stent oversizing or not-oversizing? An unresolved dilemma

2021

Primary PCI plus stent implantation is indicated for treatment of acute coronary syndrome. Technically, due to the difference in lumen diameter between vessel portions and stent size in some coronary arteries, post-expansion of the stent is usually necessary to match proximal reference diameter and optimize stent apposition. Incomplete stent apposition has been associated with increased risk of in stent restenosis (ISR) and stent thrombosis (1) despite new stent technologies have largely reduced this risk (2-3). Although new antiplatelet drugs showed a more rapid onset of action and a stronger effect (4-5), stent apposition remains an important risk factor for stent thrombosis. As stent pos…

Dilemmamedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicineMEDLINEStentStentsbusinessstent PCICardiology and Cardiovascular MedicineBlood Vessel ProsthesisSurgeryMinerva Cardiology and Angiology
researchProduct

Caffeine and cardiovascular diseases: critical review of current research.

2015

Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements. This wide use has led to concerns regarding the safety of caffeine and its proposed beneficial role in alertness, performance and energy expenditure and side effects in the cardiovascular system. The question remains "Which dose is safe?", as the population does not appear to adhere to the strict guidelines listed on caffeine consumption. Studies in humans and animal models yield controversial results, which can be explained by population, type and dose of caffeine and low statistica…

DrugSettore BIO/17 - Istologiamedia_common.quotation_subjectmedicine.medical_treatmentPopulationMedicine (miscellaneous)030204 cardiovascular system & hematologyCoffeeToxicology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMeta-Analysis as TopicEnvironmental healthCaffeinemedicineAnimalsHumanseducationmedia_commonMetabolic Syndromeeducation.field_of_studyNutrition and DieteticsDose-Response Relationship Drugbusiness.industryClinical Studies as TopicInsulin sensitivityHeartStimulantAlertnessDisease Models AnimalEnergy expenditurechemistryCaffeine consumptionCardiovascular diseases Caffeine Cardioprotective effects Pathogenesis Clinical studies Experimental studiesCardiovascular DiseasesBlood VesselsCaffeinebusiness030217 neurology & neurosurgeryEuropean journal of nutrition
researchProduct

EGFL7 ligates αvβ3 integrin to enhance vessel formation

2013

Angiogenesis, defined as blood vessel formation from a preexisting vasculature, is governed by multiple signal cascades including integrin receptors, in particular integrin αVβ3. Here we identify the endothelial cell (EC)-secreted factor epidermal growth factor-like protein 7 (EGFL7) as a novel specific ligand of integrin αVβ3, thus providing mechanistic insight into its proangiogenic actions in vitro and in vivo. Specifically, EGFL7 attaches to the extracellular matrix and by its interaction with integrin αVβ3 increases the motility of EC, which allows EC to move on a sticky underground during vessel remodeling. We provide evidence that the deregulation of EGFL7 in zebrafish embryos leads …

EGF Family of ProteinsEmbryo NonmammalianAngiogenesisAmino Acid MotifsImmunologyIntegrinGene ExpressionMice NudeEndothelial Growth FactorsBiochemistryCollagen receptorMiceCell MovementCell AdhesionHuman Umbilical Vein Endothelial CellsmedicineAnimalsHumansImmunoprecipitationPhosphorylationZebrafishbiologyReverse Transcriptase Polymerase Chain ReactionChemistryCalcium-Binding ProteinsInfarction Middle Cerebral ArteryVenous plexusCell BiologyHematologyIntegrin alphaVbeta3ImmunohistochemistryExtracellular MatrixCell biologyEndothelial stem cellHEK293 Cellsmedicine.anatomical_structureIntegrin alpha MImmunologybiology.proteinBlood VesselsRNA InterferenceIntegrin beta 6Protein BindingBlood vesselBlood
researchProduct

The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis

2011

Implantation of a retrogradely shed endometrium during menstruation requires an adequate blood supply, which allows the growth of endometriotic lesions. This suggests that the development of endometriosis can be impaired by inhibiting angiogenesis. The growth of endometriotic foci is impaired by commercial oncological antiangiogenic drugs used to block vascular endothelial growth factor (VEGF) signaling. The dopamine agonist cabergoline (Cb2) inhibits the growth of established endometriosis lesions by exerting antiangiogenic effects through VEGFR2 inactivation. However, the use of ergot-derived Cb2 is associated with an increased incidence of cardiac valve regurgitation. To evaluate the pot…

Embryologymedicine.medical_specialtyCabergolineProliferation indexAngiogenesisEndometriosisEndometriosisCell CountPharmacologyDopamine agonistClavicepsNeovascularizationEndometriumMicechemistry.chemical_compoundEndocrinologyInternal medicineCabergolinemedicineAnimalsHumansErgolinesCell ProliferationUterine DiseasesNeovascularization PathologicReceptors Dopamine D2business.industryQuinagolideObstetrics and GynecologyCell Biologymedicine.diseaseVascular Endothelial Growth Factor Receptor-2Vascular endothelial growth factorDisease Models AnimalEndocrinologyReproductive MedicinechemistryDopamine AgonistsBlood VesselsFemalemedicine.symptombusinessmedicine.drugREPRODUCTION
researchProduct

Multi-objective optimization of nitinol stent design.

2017

Nitinol stents continuously experience loadings due to pulsatile pressure, thus a given stent design should possess an adequate fatigue strength and, at the same time, it should guarantee a sufficient vessel scaffolding. The present study proposes an optimization framework aiming at increasing the fatigue life reducing the maximum strut strain along the structure through a local modification of the strut profile.The adopted computational framework relies on nonlinear structural finite element analysis combined with a Multi Objective Genetic Algorithm, based on Kriging response surfaces. In particular, such an approach is used to investigate the design optimization of planar stent cell.The r…

EngineeringCompressive Strengthmedicine.medical_treatment02 engineering and technology030204 cardiovascular system & hematologycomputer.software_genreMulti-objective optimization0302 clinical medicineStentComputer Aided DesignFatigueSafety factorStructural engineeringEquipment DesignFatigue limitFinite element methodsurgical procedures operativeComputer-Aided DesignStentsAlgorithms0206 medical engineeringFinite Element AnalysisBiophysicsBiomedical EngineeringFatigue; Multi-objective optimization; Nitinol; Stent; Structural finite element analysis; Tapered strut; Biophysics; Biomedical Engineering03 medical and health sciencesBlood vessel prosthesisElastic ModulusTensile StrengthGenetic algorithmmedicineAlloysPressureComputer Simulationcardiovascular diseasesbusiness.industryStentStructural finite element analysiNitinolModels Theoreticalequipment and supplies020601 biomedical engineeringTapered strutBlood Vessel ProsthesisMulti-objective optimizationEquipment Failure AnalysisBiophysicStress MechanicalbusinesscomputerMedical engineeringphysics
researchProduct

Bioengineered vascular scaffolds: the state of the art

2014

To date, there is increasing clinical need for vascular substitutes due to accidents, malformations, and ischemic diseases. Over the years, many approaches have been developed to solve this problem, starting from autologous native vessels to artificial vascular grafts; unfortunately, none of these have provided the perfect vascular substitute. All have been burdened by various complications, including infection, thrombogenicity, calcification, foreign body reaction, lack of growth potential, late stenosis and occlusion from intimal hyperplasia, and pseudoaneurysm formation. In the last few years, vascular tissue engineering has emerged as one of the most promising approaches for producing …

EngineeringIntimal hyperplasiaBiomedical EngineeringMedicine (miscellaneous)ThrombogenicityNew materialsBioengineeringBiocompatible MaterialsVascular graftBiomaterialsTissue engineeringBlood vessel prosthesisBiomaterials; Tissue engineering; Vascular grafts; Vascular prosthesesmedicineHumansTissue engineeringTissue Scaffoldsbusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeGeneral Medicinemedicine.diseaseBiocompatible materialBiomaterialBlood Vessel ProsthesisStenosisSettore MED/18 - Chirurgia GeneraleVascular tissue engineeringVascular prosthesesbusinessBiomedical engineering
researchProduct

Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice.

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190540 También participan en la elaboración de este artículo científico: Aracely Calatayud-Pascual, Alicia López-Castellano, Elena P. Albelda, Enrique García-España, Luis Martí-Bonmatí, Juan C. Frias y M. Teresa Albelda. Fumagillin-loaded liposomes were injected into ApoE-KO mice. The animals were divided into several groups to test the efficacy of this anti-angiogenic drug for early treatment of atherosclerotic lesions. Statistical analysis of the lesions revealed a decrease in the lesion size after 5 weeks of treatment.

Fluorescence-lifetime imaging microscopyPathologylcsh:MedicineAngiogenesis Inhibitors02 engineering and technology030204 cardiovascular system & hematologyVascular MedicineBiochemistryArteriosclerosis - Chemotherapy.Diagnostic RadiologyAteroesclerosis - Farmacoterapia.MiceWhite Blood Cells0302 clinical medicineAnimal CellsArteriosclerosis - Farmacoterapia.Medicine and Health SciencesArteries - Diseases - Treatment.Nanotechnologylcsh:ScienceAortaPhospholipidsmedia_commonMice KnockoutLiposomeDrug CarriersMultidisciplinarymedicine.diagnostic_testRadiology and Imaging021001 nanoscience & nanotechnologyMagnetic Resonance ImagingLipidsFatty Acids UnsaturatedEngineering and Technologymedicine.symptomCellular Structures and OrganellesCellular TypesAnatomy0210 nano-technologySesquiterpenesResearch ArticleDrugmedicine.medical_specialtyImaging Techniquesmedia_common.quotation_subjectImmune CellsImmunologyLiposomes.Research and Analysis MethodsLiposomas.Lesion03 medical and health sciencesText miningApolipoproteins ECyclohexanesDiagnostic Medicinemedicine.arteryFluorescence ImagingmedicineAnimalsArterias - Enfermedades - Tratamiento.VesiclesAortaBlood Cellsbusiness.industryMacrophageslcsh:RAnti angiogenicBiology and Life SciencesMagnetic resonance imagingCell BiologyAtherosclerosisFumagillin - Therapeutic use.Atherosclerosis - Chemotherapy.Disease Models AnimalFumagilina - Uso terapéutico.LiposomesCardiovascular AnatomyNanoparticlesBlood Vesselslcsh:QbusinessPloS one
researchProduct

Hsp70 is required for optimal cell proliferation in mouse A6 mesoangioblast stem cells.

2009

Mouse Hsp70 (70 kDa heat shock protein) is preferentially induced by heat or stress stimuli. We previously found that Hsp70 is constitutively expressed in A6 mouse mesoangioblast stem cells, but its possible role in these cells and the control of its basal transcription remained unexplored. Here we report that in the absence of stress, Ku factor is able to bind the HSE (heat shock element) consensus sequence in vitro, and in vivo it is bound to the proximal hsp70 promoter. In addition, we show that constitutive hsp70 transcription depends on the co-operative interaction of different factors such as Sp1 (specificity protein 1) and GAGA-binding protein with Ku factor, which binds the HSE cons…

Gene knockdownMesoangioblastBinding SitesGeneral transcription factorCell growthStem CellsCell BiologyBiologyFlow CytometryBiochemistryMolecular biologyHsp70MiceTranscription (biology)Heat shock proteinAnimalsBlood VesselsHSP70 Heat-Shock ProteinsRNA InterferenceStem cellmesoangioblast RNAi doubling timePromoter Regions GeneticMolecular BiologyCell ProliferationTranscription FactorsThe Biochemical journal
researchProduct

Endovascular stentectomy using the snare over stent-retriever (SOS) technique: An experimental feasibility study

2017

PLoS one 12(5), e0178197 (2017). doi:10.1371/journal.pone.0178197

GlycerolSwinePhysiologylcsh:Medicine030218 nuclear medicine & medical imaging0302 clinical medicinePig ModelsBlood FlowMedicine and Health SciencesMedicinelcsh:ScienceData flow modelClinical scenarioMammalsMultidisciplinaryExperimental DesignEndovascular ProceduresVasospasmAnimal ModelsProsthesis FailureBody FluidsPhysical sciencesChemistryBloodExperimental Organism SystemsResearch DesignVertebratesFemaleStentsRadiologyAnatomyResearch ArticleBiotechnologymedicine.medical_specialtyCathetersSurgical and Invasive Medical ProceduresMonomers (Chemistry)Research and Analysis Methods03 medical and health sciencesAnimal modelText miningIn vivoBlood vessel prosthesisAnimalsHumansPolymer chemistryStent retrieverbusiness.industrylcsh:ROrganismsBiology and Life Sciencesmedicine.diseaseBlood Vessel ProsthesisDisease Models AnimalStent ImplantationAmniotesFeasibility StudiesMedical Devices and Equipmentlcsh:Qbusiness030217 neurology & neurosurgeryPLOS ONE
researchProduct

Antithrombotische Therapie bei peripherer arterieller Verschlusskrankheit

2018

Was ist neu? Antithrombotische Therapie bei stabiler PAVK Die aktuellen deutschen und europäischen Leitlinien empfehlen bei Patienten mit einer peripheren arteriellen Verschlusskrankheit (PAVK) die Monotherapie mit einem Thrombozytenaggregationshemmer (ASS 100 mg oder Clopidogrel 75 mg).In der COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS) -Studie wurde Patienten mit PAVK 2 × 2,5 mg Rivaroxaban zusätzlich zu ASS 100 mg gegeben. Dies führte zur signifikanten Reduktion kardiovaskulärer Ereignisse (MACE = Major Adverse Cardiovascular Events) wie kardiovaskulärer Tod, Myokardinfarkt und Schlaganfall. Ebenfalls signifikant reduziert wurden periphere Ereignisse (MAL…

GynecologySecondary preventionmedicine.medical_specialtybusiness.industryGuideline adherenceGeneral Medicine030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicinemedicinePlatelet aggregation inhibitor030212 general & internal medicinePeripheral artery disease (PAD)businessBlood Vessel Prosthesis ImplantationFibrinolytic agentDMW - Deutsche Medizinische Wochenschrift
researchProduct